Skip to main content
Log in

Neurocysticercosis and the global world

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Carpio A, Santillan F, Leon P, Flores C, Hauser A (1995) Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 155: 1982–1988

    Article  CAS  PubMed  Google Scholar 

  2. Cicalini S, Escriba D, Francavilla R, De Rosa FG (2001) Neurocysticercosis: an unusual presentation of a rare disease. J Neurol 248: 139–140

    Article  CAS  PubMed  Google Scholar 

  3. Correa D, Medina E (1999) Host-parasite immune relationship in Taenia solium taeniasis and cysticercosis. In: Garcia HH, Martínez SM (eds) Taenia solium taeniasis/cysticercosis. 2nd Ed. Ed. Universo, Lima, pp 15–24

    Google Scholar 

  4. Del Brutto OH (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44: 1706–1709

    Article  PubMed  Google Scholar 

  5. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389–392

    Article  PubMed  Google Scholar 

  6. Dixon HBF, Hargreaves WH (1944) Cysticercosis (Taenia solium): a further ten years clinical study, covering 284 cases. Q J Med 13: 107–121

    Google Scholar 

  7. Dixon HBF, Lipscomb FM (1961) Cysticercosis: an analysis and follow-up of 450 cases. Special Report Series, Medical Research Council 299: 1–58

    Google Scholar 

  8. García HH, Gilman RH (1995) Antiparasitic therapy for neurocysticercosis. Arch Neurol 52: 941

    Article  PubMed  Google Scholar 

  9. Kramer LD (1995) Medical treatment of cysticercosis: ineffective. Arch Neurol 52: 101–102

    Article  CAS  PubMed  Google Scholar 

  10. Moodley M, Moosa A (1989) Treatment of neurocysticercosis: is praziquentel the new hope? Lancet 8632: 262–263

    Article  Google Scholar 

  11. Padma MV, Behari M, Misra NK, Ahuja GK (1995) Albendazol in neurocysticercosis. Nat Med J India 8: 255–258

    CAS  Google Scholar 

  12. Vasquez V, Sotelo J (1992) The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 327: 696–701

    Article  Google Scholar 

  13. Yoshino K (1933) Studies an the postembryonal development of Taenia solium: III. On the development of Cysticercus cellulosae within the definitive intermediate host. J Med Assoc Formosa 32: 166–169

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Hector H. Garcia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garcia, H.H., Pretell, J., Gilman, R.H. et al. Neurocysticercosis and the global world. J Neurol 249, 1107–1108 (2002). https://doi.org/10.1007/s00415-002-0722-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-002-0722-4

Keywords

Navigation